Clinical Trial Update: A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.

View source ↗

Summary

This clinical trial update discusses a Pfizer-sponsored study evaluating dacomitinib in patients with non-small cell lung cancer, with the trial currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Dacomitinib (dacomitinib)

Snippet

Sponsor: Pfizer | Conditions: Lung Cancer | Status: ACTIVE_NOT_RECRUITING